Cancer Biomarker Detection With Luminex Assays

Luminex and Bio-Techne are working together to support the development of early diagnostic solutions that detect cancer earlier through the use of proteomics.
Charles Rosser, a research scientist and professor of biomedical sciences, has developed a multiplex test for early-stage bladder cancer using Luminex® xMAP® Technology. Bladder cancer affects over 570,000 people globally each year, and the Oncuria® test aims to detect bladder cancer, monitors for recurrence, and predicts which patients will benefit from the immunotherapy treatment. Current diagnostic assays lack sensitivity and do not provide a comprehensive view of the cancer’s molecular profile, but the Oncuria® test covers 10 glycoproteins to detect the biological signature of bladder cancer with sensitivity of 90% to 93% and specificity of 86% to 95%. The test received Breakthrough Device Designation status from the FDA and is currently available as a laboratory-developed test (LDT). In a recent clinical validation study involving about 350 patients, the test offered 93% sensitivity. Learn more about this major shift in the care of patients with bladder cancer.

Multiple pathogen biomarker detection using an encoded bead array in droplet PCR.

Multiplexed Cytokines (Luminex) – DartLab

ars.els-cdn.com/content/image/1-s2.0-S153594762100

R&D Systems: Luminex® Assays

The Advantages of Multiplexing Biomarker Analysis Biocompare: The Buyer's Guide for Life Scientists

What is a Luminex Assay? Multiplex Assays: R&D Systems

The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays

Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays - Analyst (RSC Publishing) DOI:10.1039/C6AN01076H

Cancers, Free Full-Text

Lipid Metabolism Pathway Luminex Multiplex Assay - Creative Proteomics

PPT - Ovarian Cancer Early Detection Biomarkers Trials and Regulatory Issues PowerPoint Presentation - ID:9424967

Luminex® Platform – Houston Omics Collaborative

A) Diagram of Luminex based multiplex assays. Antibodies against

Cancers, Free Full-Text